MSN Laboratories is a global leader in Active Pharmaceutical Ingredient (API) development, with API production serving as a cornerstone of our business. With a portfolio of over 600+ products, we are one of the largest API portfolios in the world, catering to a wide spectrum of Therapeutic areas. Our deep expertise and robust manufacturing capabilities enables us to deliver high-quality APIs, from grams to tons. Leveraging cutting-edge technology and innovative processes, we ensure the consistent production of high-quality active pharmaceutical ingredients to meet diverse market needs.

23

Years of Presence

570+

API USDMFs

110+

Oncology APIs

19

State of the art API manufacturing Facilities

50+

Complex APIs

World No1

In Active US DMF filings- badge

500+

million patients impacted

600+

API products

75+

Therapeutic conditions

30+

Orphan Disease

Key Therapeutic Areas

Oncology
Endocrinology
Cardiology
Respiratory
CNS
Anti-inflammatory
Urology
Pain Management
Gastrointestinal
Hematology

High Expertise in

Oligonucleotides

Organic Syntheses

Heterocyclic chemistry

Carbohydrates

Solid Support Systems

Achiral Chemistry

Metal Chemistry

Azido Nitroso Impurities’ Characterization

Genotoxic Impurities’ Characterization

Complex Peptides

Iron Complexes

Polymer Chemistry

Reach Out to Us for More Info

Contact Us